MV Management XI, L.L.C. - RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.

Quarter-by-quarter ownership
MV Management XI, L.L.C. ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6,034,029
-59.0%
788,762
-60.0%
10.04%
-61.1%
Q2 2023$14,730,153
+12.0%
1,971,9080.0%25.77%
+28.0%
Q1 2023$13,152,626
-13.5%
1,971,9080.0%20.13%
-23.9%
Q4 2022$15,203,411
-27.5%
1,971,9080.0%26.45%
+74.0%
Q3 2022$20,981,000
+30.7%
1,971,9080.0%15.20%
+4.2%
Q2 2022$16,051,000
+13.7%
1,971,9080.0%14.59%
+48.8%
Q1 2022$14,119,000
-58.2%
1,971,9080.0%9.80%
-32.8%
Q4 2021$33,779,0001,971,90814.59%
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Kinnevik AB (publ) 10,405,668$79,603,360100.00%
Data Collective IV GP, LLC 5,941,120$45,449,56843.00%
MIC Capital Management UK LLP 8,451,758$64,655,95214.74%
MV Management XI, L.L.C. 788,762$6,034,02910.04%
ArchPoint Investors 1,047,386$8,012,5033.06%
Connective Portfolio Management, LLC 33,000$252,0000.77%
PLATINUM INVESTMENT MANAGEMENT LTD 2,335,132$17,863,7600.70%
Diametric Capital, LP 136,331$1,042,9320.44%
ARK Investment Management 6,876,598$52,605,9730.40%
ALLEN OPERATIONS LLC 217,657$1,665,0760.37%
View complete list of RECURSION PHARMACEUTICALS IN shareholders